Latest News in the pharma Industry
Top Stories
Croda celebrates EXCiPACT Certification across all leading excipient sites
10 May 2017
Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities.
Read more
Chemotherapy as a tablet instead of an intravenous infusion
28 Mar 2017
New production method for solid dispersions of docetaxel and paclitaxel.
Read more
Landmark outcomes study shows that Repatha decreases LDL-C to unprecedented low levels
17 Mar 2017
Amgen has announced that the 27,564-patient Repatha (evolocumab) cardiovascular outcomes study, FOURIER, established for the first time that maximally reducing low-density lipoprotein cholesterol (LDL-C) levels with Repatha, beyond what is possible wit...
Read more
Mylan announces global settlement and license Agreements with Genentech and Roche on Herceptin
13 Mar 2017
Settlement provides Mylan with global licenses for its trastuzumab product.
Read morePharma's most innovative companies; the 2017 ranking
28 Feb 2017
Innovation is being driven increasingly by smaller, possibly more agile, companies.
Read more
Can yeast rise to the challenge of curing cancer?
21 Feb 2017
Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells.
Read more
Turbofer: innovative formulation for iron deficiency
16 Feb 2017
NTC Pharma expands its product portfolio with a new food supplement containing iron pyrophosphate microencapsulated in liposomal form, Turbofer orosoluble granules.
Read more
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic
23 Jan 2017
The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.
Read more
Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease
17 Jan 2017
Therapies targeted at this novel mechanism have the potential for disease-modification because they will address the genetic root cause of AD.
Read more
Ariad to be acquired by Takeda for $5.2 billion
9 Jan 2017
Ariad stockholders to receive $24.00 per share in cash.
Read more
Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic
16 Dec 2016
Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector.
Read more
Lonza to acquire Capsugel
15 Dec 2016
Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets.
Read more